{
  "url": "https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-regulations-2013/schedule-5/paragraph-22",
  "json_url": "https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-regulations-2013/schedule-5/paragraph-22.json",
  "legislation": "uksi/2013/349",
  "legislation_title": "The National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013",
  "legislation_url": "https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-regulations-2013",
  "path": "schedule/5/paragraph/22",
  "kind": "paragraph",
  "number": "22",
  "heading": "Other information to be supplied",
  "text": "(1) An NHS appliance contractor (C) must give notice to NHS England within 30 days (or if this is impracticable, as soon as practicable thereafter) of—\n(a) any occurrence requiring a change in the information recorded about C in the pharmaceutical list which C has not otherwise notified to NHS England in accordance with these Regulations;\n(b) if C is an individual, any change of C's private address;\n(c) if C is a body corporate, any change to the name, registered number, registered office, telephone number relating to that office of the body corporate; and\n(d) any occurrence requiring C's addition to or removal from the EPS list or a change in the information recorded about C in that list.\n(2) C must give NHS England, if it so requests, the name of any pharmacist employed or engaged by C who is responsible for dispensing a particular prescription.\n(3) If C is a body corporate, it must give notice to NHS England within 30 days (or if this in impracticable, as soon as practicable thereafter) of any changes to the names and addresses of each of its directors.\n(4) If C is a body corporate and appoints a director who was not listed on C's application for inclusion on a pharmaceutical list, C must, within 30 days of the person's appointment, supply to NHS England the information mentioned in paragraphs 3 and 4 of Schedule 2 about that person.\n(5) If C or a director of C (if C is a body corporate) is on, or is a director of a body corporate which is on, a relevant list other than a pharmaceutical list held by NHS England, they must supply in writing to NHS England—\n(a) in the case of a director of a body corporate, the name and registered office of the body corporate on the other relevant list; and\n(b) particulars of the other relevant list.\n(6) C or a director C (if C is a body corporate) must inform NHS England if they, or a body corporate of which they are a director, apply to be included in a relevant list other than a pharmaceutical list held by NHS England, and of the outcome of any such application.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Words in Regulations substituted (6.11.2023) by The Health and Care Act 2022 (Further Consequential Amendments) (No. 2) Regulations 2023 (S.I. 2023/1071), reg. 1(1), Sch. para. 1"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2013/349/schedule/5/paragraph/22",
    "retrieved_at": "2026-10-29T01:03:55.705659+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}